Search Orphan Drug Designations and Approvals
-
| Generic Name: | Adeno-associated viral vector encoding the human frataxin (FXN) gene, AAVrh.10hFXN |
|---|---|
| Date Designated: | 06/24/2021 |
| Orphan Designation: | Treatment of patients with cardiac disease associated with Friedreich’s Ataxia (FA) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Lexeo Therapeutics 430 East 29th Str 14th Floor New York, New York 10016 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







